Safety and efficacy of double antithrombotic therapy with non–vitamin k antagonist oral anticoagulants in patients with atrial fibrillation undergoing percutaneous …

D Capodanno, M Di Maio, A Greco… - Journal of the …, 2020 - Am Heart Assoc
Background The optimal antithrombotic therapy for patients with atrial fibrillation undergoing
percutaneous coronary intervention is a topic of debate. We aimed at defining the efficacy …

Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic …

G Gargiulo, A Goette, J Tijssen, L Eckardt… - European heart …, 2019 - academic.oup.com
Aims To investigate the safety and efficacy of double vs. triple antithrombotic therapy (DAT
vs. TAT) in patients with atrial fibrillation (AF) and acute coronary syndrome or who …

Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous …

G Gargiulo, CP Cannon, CM Gibson… - European Heart …, 2021 - academic.oup.com
Aims Safety and efficacy of antithrombotic regimens in patients with atrial fibrillation (AF)
undergoing percutaneous coronary intervention (PCI) may differ based on clinical …

Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary …

TS Potpara, N Mujovic, M Proietti, N Dagres… - EP …, 2020 - academic.oup.com
Aims Recently, three randomized trials reported that dual antithrombotic treatments (DATs)
including non-vitamin K antagonist oral anticoagulants (NOACs) and a P2Y12 inhibitor …

[HTML][HTML] Non-vitamin K oral anticoagulants (NOAC) versus vitamin K antagonists (VKA) for atrial fibrillation with elective or urgent percutaneous coronary intervention …

C Eyileten, M Postula, D Jakubik, A Toma… - Journal of clinical …, 2020 - mdpi.com
Background: Our study aims to perform a meta-analysis of benefits and risks associated with
the use of non-vitamin K oral anticoagulants (NOAC) versus vitamin K antagonists (VKA) in …

Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials

G Ando, F Costa - International Journal of Cardiology, 2020 - Elsevier
Aims Double or triple antithrombotic therapy (DAT/TAT) including or excluding aspirin in
association with oral anticoagulant and P2Y12 inhibitor are currently two available options …

Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of …

RD Lopes, H Hong, RE Harskamp, DL Bhatt… - Jama …, 2019 - jamanetwork.com
Importance The antithrombotic treatment of patients with atrial fibrillation (AF) and coronary
artery disease, in particular with acute coronary syndrome (ACS) and/or percutaneous …

Meta-analysis comparing the safety and efficacy of dual versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary …

I Cavallari, G Patti - The American journal of cardiology, 2018 - Elsevier
In patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI), the
effectiveness and safety of dual compared with triple antithrombotic therapy are a matter of …

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review

D Capodanno, K Huber, R Mehran, GYH Lip… - Journal of the American …, 2019 - jacc.org
Most patients with atrial fibrillation (AF) and risk factors for stroke require oral anticoagulation
(OAC) to decrease the risk of stroke or systemic embolism. This is now best achieved with …

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta …

HB Golwala, CP Cannon, PG Steg, G Doros… - European heart …, 2018 - academic.oup.com
Aims Of patients with atrial fibrillation (AF), approximately 10% undergo percutaneous
coronary intervention (PCI). We studied the safety and efficacy of dual vs. triple …